Clinical Trials Directory

Trials / Conditions / Primary Hyperoxaluria Type 1 (PH1)

Primary Hyperoxaluria Type 1 (PH1)

7 registered clinical trials studyying Primary Hyperoxaluria Type 1 (PH1) — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
NCT06839235
Arbor BiotechnologiesPhase 1 / Phase 2
CompletedA Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluri
NCT03847909
Novo Nordisk A/SPhase 2
Active Not RecruitingLong Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyPhase 3
CompletedA Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1
NCT03905694
Alnylam PharmaceuticalsPhase 3
CompletedA Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
NCT03681184
Alnylam PharmaceuticalsPhase 3
CompletedStudy of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1
NCT02706886
Alnylam PharmaceuticalsPhase 1 / Phase 2
No Longer AvailableTreatment of Primary Hyperoxaluria Type 1 With Nedosiran
NCT05993416
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company—